Progyny Health (PGNY) - Kapitalizatsiyaning foydaga nisbati

Progyny Health - PGNY emitenti grafik logotipi

Progyny, Inc. (PGNY) reproduktiv imtiyozlarni boshqarish sohasida favqulodda nufuzga ega, buni kompaniyaning joriy P/E koeffitsiyenti tasdiqlaydi. 30.20 qiymati joriy bozor baholash ko'rsatkichi bilan mos keladi. Ish beruvchilar va klinikalarning yagona servisga integratsiyasi mijozlarning yuqori sodiqligini ta'minlaydi. Yirik korporativ mijozlarning doimiy oqimi o'sib borayotgan tibbiy imtiyozlar sektorida bozor ulushining barqaror kengayishini kafolatlaydi.

Progyny Corp - PGNY Narx-foyda koeffitsiyenti (davr: 04.07.2022 - 17.11.2026)

Progyny, Inc. kompaniyasining tahliliy kesimlari

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Kompaniyaning har tomonlama tahlili:PGNY (Progyny)
Progyny Corp tomonidan chiqariladigan mahsulotlar

Muvaffaqiyatli homiladorlikni ta'minlash uchun Smart Cycle modelini kengaytirish Progyny, Inc. (PGNY) kompaniyasining tuzatilgan P/E ko'rsatkichiga bevosita ta'sir ko'rsatadi va bir dollar sof foydaning bozor qiymatini aks ettiradi. Ushbu koeffitsient joriy bozor kapitalizatsiyasini moliyaviy natijalar bilan solishtiradi, bu esa investorlarga Progyny, Inc. (PGNY) biznes modeli uchun to'langan premiumni baholash va bozor kutuvlari nuqtai nazaridan investitsiyalarning qoplanish muddatlarini prognoz qilish imkonini beradi.

Muhim raqobatchilar

Kapitalizatsiyaning foydaga nisbati hcahealthcare.com HCA|Narxning foydaga nisbati Tenet Healthcare (THC)|Fresenius Medical Care - Narx-foyda multiplikatori|Narxning foydaga nisbati Solventum SOLV|Bozor narxining sof foydaga nisbati EHC (Encompass Health)|UHS: Narx-foyda koeffitsiyenti|DVA (DaVita) - Narx-foyda multiplikatori|RadNet Corp (RDNT) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Option Care Corp (OPCH)|Narx-foyda koeffitsiyenti SGRY|PINC: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori EYE|Ardent Health Partners - Narx-foyda multiplikatori|P/E multiplikatori SEM (Select Medical Inc.)|Kompaniya qiymatining sof foydaga nisbati ASTH|MD - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati USPH (U.S. Physical Therapy, Inc.)|PNTG: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Organogenesis (ORGO)|NUTX (Nutex Health Corp) - P/E multiplikatori|P/E multiplikatori Auna Health|P/E multiplikatori SBC|Biznesning o‘zini qoplash muddati evolus.com|Community Health Systems, Inc. - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati SKIN (beautyhealth.com)|MDWD: Narx-foyda koeffitsiyenti|Kapitalizatsiyaning sof foydaga nisbati BTMD|JYNT: P/E multiplikatori|Narx-foyda multiplikatori DCGO|PIII (P3 Health Partners Inc.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Gain Therapeutics, Inc. GANX|Narx-foyda koeffitsiyenti EUDA (EUDA Health Holdings)|Narxning foydaga nisbati BMGL (Basel Medical Group Limited)|CollPlant Biotechnologies Ltd. - Narx-foyda koeffitsiyenti|CUPR: Narx-foyda multiplikatori|CCM: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati AMS (American Shared Hospital Services)|MRM: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Avalon GloboCare Corp (ALBT)|Narxning foydaga nisbati DIH Holding|XAGE: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori NIVF|P/E multiplikatori ATI Physical Therapy Inc. (ATIP)|P/E multiplikatori CMAX (caremax.com)|Bozor narxining sof foydaga nisbati KDLY (Kindly Health)|MODV - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati novointegrated.com|SunLink Health Systems (SSY) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti IMAC Holdings Inc